These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10601322)

  • 21. p53-dependent down-regulation of telomerase is mediated by p21waf1.
    Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
    J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.
    Won J; Yim J; Kim TK
    J Biol Chem; 2002 Oct; 277(41):38230-8. PubMed ID: 12151407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
    Horikawa I; Cable PL; Afshari C; Barrett JC
    Cancer Res; 1999 Feb; 59(4):826-30. PubMed ID: 10029071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
    Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
    Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of a human gene involved in transcriptional regulation of hTERT.
    Tang Z; Zhao Y; Mei F; Yang S; Li X; Lv J; Hou L; Zhang B
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1324-32. PubMed ID: 15504359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene.
    Wang ZY; Madden SL; Deuel TF; Rauscher FJ
    J Biol Chem; 1992 Nov; 267(31):21999-2002. PubMed ID: 1429549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
    Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
    J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
    Johnstone RW; See RH; Sells SF; Wang J; Muthukkumar S; Englert C; Haber DA; Licht JD; Sugrue SP; Roberts T; Rangnekar VM; Shi Y
    Mol Cell Biol; 1996 Dec; 16(12):6945-56. PubMed ID: 8943350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun.
    Dejong V; Degeorges A; Filleur S; Ait-Si-Ali S; Mettouchi A; Bornstein P; Binétruy B; Cabon F
    Oncogene; 1999 May; 18(20):3143-51. PubMed ID: 10340386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
    Casillas MA; Brotherton SL; Andrews LG; Ruppert JM; Tollefsbol TO
    Gene; 2003 Oct; 316():57-65. PubMed ID: 14563552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
    Oh ST; Kyo S; Laimins LA
    J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor.
    Goueli BS; Janknecht R
    Oncogene; 2003 Sep; 22(39):8042-7. PubMed ID: 12970752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.